Multiple Molecules See UK Prices Double In March
Pricewatch UK – March 2021
Executive Summary
Etoricoxib, letrozole and trimethoprim experienced triple-digit rises in their average UK trade prices in March, according to the latest figures from WaveData.
You may also be interested in...
Etoricoxib Leads Biggest UK Price Rises In April
Etoricoxib led the steepest price rises for UK generics in April, with the non-steroidal anti-inflammatory drug seeing average prices almost double.
Olmesartan Prices Treble In UK
Average UK trade prices of olmesartan as much as trebled across multiple presentations in the second month of 2021. However, this was not the only triple-digit price rise seen during February, WaveData reveals.
Amgen Delivers On Launch Of First US Humira Rival – At A 55% Discount
Amgen has confirmed its long-awaited launch of Amjevita, the first US biosimilar rival to Humira, kicking off a year of competition that will also see a second wave of adalimumab products launch in six months’ time. The company has announced that it will offer the product at a 55% discount to the originator.